GB0721092D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0721092D0 GB0721092D0 GBGB0721092.5A GB0721092A GB0721092D0 GB 0721092 D0 GB0721092 D0 GB 0721092D0 GB 0721092 A GB0721092 A GB 0721092A GB 0721092 D0 GB0721092 D0 GB 0721092D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0721092.5A GB0721092D0 (en) | 2007-10-26 | 2007-10-26 | Compounds |
PCT/EP2008/064408 WO2009053449A1 (en) | 2007-10-26 | 2008-10-24 | Thiazoles which potentiate ampa receptor and medicinal uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0721092.5A GB0721092D0 (en) | 2007-10-26 | 2007-10-26 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0721092D0 true GB0721092D0 (en) | 2007-12-05 |
Family
ID=38830045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0721092.5A Ceased GB0721092D0 (en) | 2007-10-26 | 2007-10-26 | Compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0721092D0 (en) |
WO (1) | WO2009053449A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2915405A1 (en) * | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
JP2018530749A (en) * | 2015-08-31 | 2018-10-18 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | Opioid receptor modulators and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE627278A (en) * | 1962-01-19 | |||
GB0608272D0 (en) * | 2006-04-26 | 2006-06-07 | Glaxo Group Ltd | Compounds |
-
2007
- 2007-10-26 GB GBGB0721092.5A patent/GB0721092D0/en not_active Ceased
-
2008
- 2008-10-24 WO PCT/EP2008/064408 patent/WO2009053449A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009053449A1 (en) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0706793D0 (en) | Compounds | |
GB0704407D0 (en) | Compounds | |
GB0704394D0 (en) | Compounds | |
GB0705672D0 (en) | Compounds | |
GB0706173D0 (en) | Compounds | |
GB0707092D0 (en) | Compounds | |
GB0706188D0 (en) | Compounds | |
GB0706165D0 (en) | Compounds | |
GB0706168D0 (en) | Compounds | |
GB0707034D0 (en) | Compounds | |
GB0721094D0 (en) | Compounds | |
GB0706167D0 (en) | Compounds | |
GB0706174D0 (en) | Compounds | |
GB0706187D0 (en) | Compounds | |
GB0706189D0 (en) | Compounds | |
GB0706170D0 (en) | Compounds | |
GB0706190D0 (en) | Compounds | |
GB0706164D0 (en) | Compounds | |
GB0721092D0 (en) | Compounds | |
GB0704939D0 (en) | Compounds | |
GB0703756D0 (en) | Compounds | |
GB0701985D0 (en) | Compounds | |
GB0701955D0 (en) | Compounds | |
GB0706290D0 (en) | Compounds | |
GB0700287D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |